Skip to main content
Caplight Logo









VeCollal

VeCollal

Private
AntwerpHealthcare & Life Scienceshttps://www.vecollal.eu/

Last Round

Early Funding

Dec 4, 2025

Company Overview

VeCollal is a biotechnology company that develops plant-based, biomimetic collagen alternatives for use in the nutraceutical and cosmetic industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Fashion & Beauty

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

biomimetic collagenvegan collagenplant-based collagennutraceutical ingredientscollagen alternativescosmetic ingredientsfunctional food ingredientswhite-label supplementsfermentation technologybio-identical collagenlab-grown collagencollagen synthesisB2B ingredient supplybiotech ingredientssustainable beauty

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VeCollal Comparables

Compare VeCollal with similar companies based on industry and business-model similarity.

VeCollal comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Jellatech
91%
Provenance Bio
87%
Geltor
82%

VeCollal Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingDec 4, 2025

VeCollal Investors

Notable investors and investment history

VeCollal investors
InvestorRounds
Seventure PartnersEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2026

    Monthly visitors increased 517% MoM, reaching 6.8K.

  • Feb 1, 2026

    Monthly visitors grew 168% MoM, reaching 1.1K.

VeCollal Filings

Explore SEC and related filing metadata, where available.

VeCollal filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about VeCollal's valuation, stock price, and market status.

Is VeCollal a public or private company?

VeCollal is a private company.

What is the current stock price of VeCollal?

VeCollal is a private company with no public stock price. No recent secondary market data is available.

How much is VeCollal worth (valuation)?

Valuation information for VeCollal is not publicly available.

Can I buy VeCollal stock?

VeCollal shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was VeCollal's last funding round?

VeCollal's most recent funding round was Early Funding on December 4, 2025.

Who are the main investors in VeCollal?

Key investors in VeCollal include Seventure Partners.

Will VeCollal IPO soon?

No public IPO plans have been announced for VeCollal.

How can I track VeCollal secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor VeCollal's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAntwerp
Employee Range5
Year Founded2020
Last FundingDec 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?